Location History:
- New South Wales, AU (2007)
- Turramurra, AU (2012)
Company Filing History:
Years Active: 2007-2012
Title: Innovations by Cassandra Jean Vockler
Introduction
Cassandra Jean Vockler is an accomplished inventor based in Turramurra, Australia. She has made significant contributions to the field of genetic research, particularly in the treatment of nucleic acids. With a total of 2 patents, her work has the potential to advance methodologies in genetic analysis and treatment.
Latest Patents
Cassandra's latest patents include innovative methods for the treatment of nucleic acids. One patent focuses on the "Bisulphite reagent treatment of nucleic acid," which involves providing an alkali environment to a nucleic acid sample, reacting it with a bisulphite reagent, and incubating the reaction to form a treated nucleic acid sample. This method ensures that methylated nucleotides remain unchanged while unmethylated nucleotides are converted to another form. The process also includes steps for removing unwanted reagents and carrying out de-sulphonation to obtain a nucleic acid sample that is substantially free of sulphonate groups. Another patent addresses the "Treatment of methylated nucleic acid," which outlines similar steps for treating methylated nucleic acids, emphasizing the importance of reducing salt concentration and precipitating the treated nucleic acid.
Career Highlights
Cassandra is currently associated with Human Genetic Signatures Pty. Ltd., where she applies her expertise in genetic research. Her innovative approaches have positioned her as a key figure in her field, contributing to advancements in genetic methodologies.
Collaborations
Cassandra has collaborated with notable colleagues, including Douglas Spencer Millar and Neralie Ann Coulston. These collaborations have fostered a productive environment for innovation and research in genetic treatments.
Conclusion
Cassandra Jean Vockler's contributions to the field of genetic research through her patents and collaborations highlight her role as a significant inventor. Her work continues to pave the way for advancements in nucleic acid treatment methodologies.